Showing posts with label advertising. Show all posts
Showing posts with label advertising. Show all posts

Saturday, September 20, 2008

HEALTH NEWS: NJ Launches Campaign Against Medicine Abuse

(previously published here at www.thebulletin.us)

The Partnership for a Drug-Free New Jersey (PDFNJ) announced Monday a statewide public service campaign titled "Grandma's Stash," to raise awareness that misuse of prescription drugs is second only to marijuana as America's most prevalent drug problem.

The award-winning multi-media effort will utilize newspapers, radio stations, billboards, buses and trains to spread the message that "more teens now say it's easier to get powerful prescription drugs than it is to buy beer," as Department of Human Services Commissioner Jennifer Velez said at the press conference in Lawrenceville.

Her assertion is based on findings from the National Center on Addiction and Substance Abuse (CASA) at Columbia University's 13th annual back-to-school survey of 1,002 teens and parents. The survey asked: "Which is easiest for someone your age to buy: cigarettes, beer, marijuana, or prescription drugs such as Oxycontin, Percocet, Vicodin or Ritalin, without a prescription?"

While the overall response had teens saying cigarettes and marijuana were easiest to purchase, they also said prescription drugs were easier to get than beer. Nineteen percent of teens, compared to 13 percent a year ago, found prescription drugs are easier to get than all three of the other substances.

Over 720 New Jersey pharmacies will also distribute around 750,000 prevention messages on pharmacy bags. "[This initiative is a] great example of a public-private-nonprofit collaboration that can positively impact the lives of hundreds of thousands of New Jersey families," said Joseph Roney, R. Ph. FACP/CEO, of the New Jersey Pharmacist Association in a PDFNJ press release.

Columbia's 2008 CASA survey report also noted that many of the parents surveyed are "problem parents" whose actions - or lack thereof - increased the abuse of illegal and prescription drugs among 12- to 17-year-olds. Thirty-four percent of teens surveyed who abused prescription drugs obtained them at home, and half of those allowed out after 10 p.m. said they spent time with smokers and drug users.

There are lots of factors at play here," Elizabeth Planet, CASA's director of special projects, said to the Washington Post of the behavior differences revealed in the study. "Parents are not paying attention. There are parents who are out in the evening themselves. There are parents out at work."

"In the 2007 New Jersey Middle School Principals Study, half of the principals surveyed indicated that they believed prescription drugs were abused more than twice that of ecstasy and cocaine by their students," Joseph A. Miele, PDFNJ chairman, said at the press conference. "[Yet] the 2007 PDFNJ Parent Tracking Survey found that 44 percent of New Jersey parents of middle school students said they knew little or just about nothing about prescription drug abuse."

It is also necessary for kids to understand the risks involved with misusing prescription drugs.

"Kids [may] think that because these are medicines that are prescribed, they are safe," said Nora Volkow, director of the National Institute on Drug Abuse. "The problem is that there is very little difference between the amount they take for a high and the amount that causes an overdose."

So keeping the lines of communication open and the medicine cabinet closed is incredibly important, she said.

Joseph Califano, CASA chairman and president, told the Post he recommends more than three family dinners a week, while Steve Pasierb, president of Partnership for a Drug-Free America suggested to WebMD that parents engage in "a lot of smaller conversations that aren't so scary" compared to a big, intimidating talk.

The "Grandma's Stash" campaign also commemorates August as National Medicine Abuse Awareness Month, a designation passed this July by the U.S. Senate in light of a recent Substance Abuse and Mental Health Services Administration report about the increasing rates of prescription drug abuse.


Heather J. Chin can be reached at hchin@thebulletin.us

©The Evening Bulletin 2008

Saturday, June 28, 2008

Big Pharma Agrees To Stricter Ad Rules


(previously published here at thebulletin.us)

Washington - Top drug manufacturers including Johnson & Johnson, Merck and Pfizer agreed last Monday to a six-month moratorium on direct-to-consumer television advertising for new prescription drugs and limitations on how doctors are used in their ads.

The agreements came amid increasing pressure from the Congressional House Energy and Commerce Committee and the American Medical Association (AMA) following earlier controversy surrounding deceptive advertising for anti-cholesterol drugs such as Lipitor, Procrit and Vytorin.

In signed letters, the executive directors of Johnson & Johnson, (J&J), Merck & Co., Merck/Schering-Plough, and Pfizer agreed to take steps towards implementing these recommendations.

Meanwhile, the Pharmaceutical Research and Manufacturers of America (PhRMA) agreed to further meetings with the committee before agreeing to any particular changes at the moment.

All of the companies agreed to adhere to the AMA's guidelines as to the use of actors and health professionals. Specifically, they will continue to identify instances in which an actor portrays a physician, as well as whether the actor was compensated for their appearance. Johnson & Johnson will discontinue use of doctors entirely to discuss the benefits of a drug.

In the letters, each company also stated that the six-month moratorium simply formalized their existing practice of educating doctors before moving to consumer communications.

"We have adopted internal guiding practices on direct-to-consumer advertising for prescription drugs [that] requires our operating companies spend at least six months after approval of a new medicine educating health professionals before commencing a direct-to-consumer advertising campaign," wrote William C. Weldon, chairman-CEO of J&J.

He added that since the advertisements are in line with FDA approved labeling and measures of outcomes, they are an important tool to provide information to patients and physicians, and "a particular fixed period of time for an advertising moratorium is appropriate in all circumstances."

Rep. John Dingell, D-Mich., and Rep. Bart Stupak, D-Mich., chairmen of the committee's oversight and investigations panel, said they were pleased with this response, but wanted the drug companies to adopt the recommended two-year moratorium.

According to Mr. Stupak, he and Mr. Dingell called for the May 8 hearing of the House Energy and Commerce Committee, entitled "Direct to Consumer Advertising: Marketing, Education or Deception?", to both renew pressure and renew the struggle within Congress to strengthen government regulation over such TV commercials. It was also a step towards granting the Food and Drug Administration the right to force changes in the ads before they air.

"Although we appreciate the drug companies' willingness to change some of their business practices, they have not agreed to all of our requests, which would protect consumers from misleading and deceptive advertising," said Mr. Stupak.

Even with these agreements and the potential for future legislation, the debate will go on. Part of that debate lies in the fact that running these ads is mutually beneficial for both the pharmaceutical companies and the TV industry.

Since 1997, when the government relaxed rules on TV and radio ads, pharmaceutical companies shortened the warnings on side effects in their commercials and spent about $14 million on broadcast and cable TV ads for prescription drugs.

In 2007, drug makers spent over $5 billion on direct-to-consumer ads, according to Nielsen Monitor-Plus; more than half of that on television.

"The drug and TV and cable industries have formed a cabal here to protect their revenues," said Gene Kimmelman of Consumers Union, an advocacy group in favor of stricter limits on direct-to-consumer drug marketing.

Ken Johnson, a PhRMA vice president, challenged that in a May article in the Wall Street Journal. He insisted that consumer advertising for prescription drugs "brings patients into their doctors' offices and helps start important doctor-patient conversations about conditions that might otherwise go undiagnosed or untreated."

Still, many consider the ads to be intentionally misleading. "Direct-to-consumer ads often portray drugs through rose-colored glasses by including more information about a drug's benefits than risks," said Dr. Nancy Nielsen, AMA President-elect, in testimony at the congressional hearings.

"Imbalances in these ads can diminish patient understanding of certain drug risks, and increase the need for an ongoing dialogue between patients and physicians about the benefits and risks of prescription drugs," Dr. Nielsen added.

Reporting contributed by AdAge.com and The Wall Street Journal.

Heather Chin can be reached at heather.jean.chin@gmail.com

©The Evening Bulletin 2008